WEISBLUM ERIC (CHIEF EXECUTIVE OFFICER) purchased 0.6% of their position (1K shares) of SILO PHARMA, INC. on the open market
Open‑market purchase worth $2.0K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 4/8/2024ACC: 0001213900-24-031159
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2020
+1K
Net shares
Net buyer
$2.0K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
1K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+600.00
Price / share
$1.96
Trade value
$1.18K
% of position
0.3%
4/4/2024
174.43K→175.03K
Common Stock
Direct
Shares
+400.00
Price / share
$2.03
Trade value
$812.00
% of position
0.2%
4/5/2024
175.03K→175.43K
Total
Net shares
+1K
Net value
$1.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/4/2024 | P · Purchase | +600.00 | $1.96 | $1.18K | 0.3% | 174.43K | 175.03K |
| Common Stock Direct | 4/5/2024 | P · Purchase | +400.00 | $2.03 | $812.00 | 0.2% | 175.03K | 175.43K |
| Total | +1K | $1.99K | ||||||
Derivative Transactions0
No derivative transactions reported